With its innovative functional assay platform for G-protein-coupled receptor (GPCR), Tanso Biosciences promotes human health by expanding frontiers in drug discovery and accelerating research & development.
Drug Discovery Enterprise
We take advantage of our all-around assay technology and engage in drug discovery for orphan GPCRs.
Panel assays, concentration dependence analysis, and other functional assays for > 300 orphan and non-orphan GPCRs.
- On-target and off-target screening for drug discovery
- Compound profiling
- Strategy development
- In-licensing assessment
- Drug repurposing
Characterizes compounds' potency, not affinity, on target GPCR in various modes
Dramatically and specifically amplifies G-protein-dependent signals
All GPCRs are amenable in single assay format, regardless of Gα proteins coupled
Voice of Client
Shown below are a few use cases of our assay platform.
TAK-875, an antidiabetic agent, against 48 GPCRs associated with endocrinology and metabolism
Agonist-induced concentration-dependent activation of LPAR6, a G12/13-coupled receptor
News & Events
Send us a message via the form below or write to us at [email protected].
Service Flow Chart
Request for Quotation
Tell us about the types of tests you need, the number of compounds, the receptors of interest, and other preferences. A non-disclosure agreement is optional.
A non-disclosure agreement is optional.
The client ships test compounds to our laboratory. We usually perform assays and write a report in three weeks from the receipt of the compounds.
Receipt of the Report
We provide the report and raw data for the client via email or a cloud service.